Medical writing in the Russian Federation: Promises and pitfalls. (1st June 2013)

• Record Type: Journal Article
• Authors: Davydova, Anna
• Is Part Of: Medical writing. Volume 22:Number 2(2013:Jun.)
• Page Start: 121
• Page End: 123
• Publication Date: 2013-06-01
• Subjects: Russia -- Medical writing -- Clinical trials -- Regulatory requirements; Medical writing -- Periodicals; 808.0666105
• DOI: 10.1179/2047480613Z.000000000109
• Languages: English
• ISSNs: 2047-4806

Abstract

Abstract : More and more clinical studies are taking place in Russia, making it an attractive market for medical writing. In 2011, the Ministry of Healthcare of the Russian Federation approved over 550 new clinical studies of all types, a 16% increase over the previous year. Currently, the Russian government is making huge investments in its infrastructure for drug development. Demand for medical writing is high in the rapidly growing sector of biotechnology in Russia. Because there are some differences in local requirements compared to the EU or USA, many specific regulatory aspects have to be considered by medical writers in Russia.